Search Results

• • 17 

    Academic Journals

  • Sort by: sorttype.publication.date.desc Newest sorttype.publication.date.asc Oldest sorttype.relevance Relevance

• Dysregulated T-Helper Type 1 (Th1):Th2 Cytokine Profile and Poor Immune Response in Pregnant Ferrets Infected With 2009 Pandemic Influenza A(H1N1) Virus

  Authors:Sun-Woo Yoon, Sook-San Wong, Huachen Zhu, Rirong Chen, and Long LiFrom:Journal of Infectious Diseases (Vol. 217, Issue 3) Peer-Reviewed

  Feb. 1, 2018 Article

   Citation Only

• Immunogenicity of Different Routine Poliovirus Vaccination Schedules: A Randomized, Controlled Trial in Karachi, Pakistan

  Authors:Ali F Saleem, Ondrej Mach, Mohammad T Yousafzai, Asia Khan, and William C WeldonFrom:Journal of Infectious Diseases (Vol. 217, Issue 3) Peer-Reviewed

  Feb. 1, 2018 Article

   Citation Only

• PD-L1 Overexpression During Endotoxin Tolerance Impairs the Adaptive Immune Response in Septic Patients via HIF1alpha

  Authors:Jose Avendano-Ortiz, Charbel Maroun-Eid, Alejandro Martin-Quiros, Victor Toledano, and Carolina Cubillos-ZapataFrom:Journal of Infectious Diseases (Vol. 217, Issue 3) Peer-Reviewed

  Feb. 1, 2018 Article

   Citation Only

• HIV Infection and Circulating Levels of Prosurfactant Protein B and Surfactant Protein D

  Authors:Meredith S Shiels, Gregory D Kirk, M Bradley Drummond, Dilsher Dhillon, and Samir M HanashFrom:Journal of Infectious Diseases (Vol. 217, Issue 3) Peer-Reviewed

  Feb. 1, 2018 Article

   Citation Only

• High Level of Neutrophil Extracellular Traps Correlates With Poor Prognosis of Severe Influenza A Infection

  Authors:Liuluan Zhu, Lu Liu, Yue Zhang, Lin Pu, and Jingyuan LiuFrom:Journal of Infectious Diseases (Vol. 217, Issue 3) Peer-Reviewed

  Feb. 1, 2018 Article

   Citation Only

• Recovery of Infectious Hepatitis C Virus From Injection Paraphernalia: Implications for Prevention Programs Serving People Who Inject Drugs

  Authors:Robert Heimer, Mawuena Binka, Stephen Koester, Jean-Paul C Grund, and Amisha PatelFrom:Journal of Infectious Diseases (Vol. 217, Issue 3) Peer-Reviewed

  Feb. 1, 2018 Article

   Citation Only

• Streptococcus pneumoniae From Patients With Hemolytic Uremic Syndrome Binds Human Plasminogen via the Surface Protein PspC and Uses Plasmin to Damage Human Endothelial Cells

  Authors:Christian Meinel, Giuseppina Sparta, Hans-Martin Dahse, Franziska Horhold, and Rainer KonigFrom:Journal of Infectious Diseases (Vol. 217, Issue 3) Peer-Reviewed

  Feb. 1, 2018 Article

   Citation Only

• Serum Albumin as a Prognostic Marker for Serious Non-AIDS Endpoints in the Strategic Timing of Antiretroviral Treatment (START) Study

  Authors:Andreas Ronit, Shweta Sharma, Jason V Baker, Rosie Mngqibisa, and Tristan DeloryFrom:Journal of Infectious Diseases (Vol. 217, Issue 3) Peer-Reviewed

  Feb. 1, 2018 Article

   Citation Only

• Prevalence and Genetic Variability of Human Polyomaviruses 6 and 7 in Healthy Skin Among Asymptomatic Individuals

  Authors:Yumiko Hashida, Tomonori Higuchi, Shigenobu Matsuzaki, Kimiko Nakajima, and Shigetoshi SanoFrom:Journal of Infectious Diseases (Vol. 217, Issue 3) Peer-Reviewed

  Feb. 1, 2018 Article

   Citation Only

• Intestinal Immune Responses to Type 2 Oral Polio Vaccine (OPV) Challenge in Infants Previously Immunized With Bivalent OPV and Either High-Dose or Standard Inactivated Polio Vaccine

  Authors:Elizabeth B Brickley, Carolyn B Strauch, Wendy F Wieland-Alter, Ruth I Connor, and Shu LinFrom:Journal of Infectious Diseases (Vol. 217, Issue 3) Peer-Reviewed

  Feb. 1, 2018 Article

   Citation Only

• Single-Cell Tracking Reveals a Role for Pre-Existing CCR5+ Memory Th1 Cells in the Control of Rhinovirus-A39 After Experimental Challenge in Humans

  Authors:Lyndsey M Muehling, Ronald B Turner, Kenneth B Brown, Paul W Wright, and James T PatrieFrom:Journal of Infectious Diseases (Vol. 217, Issue 3) Peer-Reviewed

  Feb. 1, 2018 Article

   Citation Only

• Hepatic Pharmacokinetics and Pharmacodynamics With Ombitasvir/Paritaprevir/Ritonavir Plus Dasabuvir Treatment and Variable Ribavirin Dosage

  Authors:Andrew H Talal, Emily O Dumas, Barbara Bauer, Richard M Rejman, and Andrew OcqueFrom:Journal of Infectious Diseases (Vol. 217, Issue 3) Peer-Reviewed

  Feb. 1, 2018 Article

   Citation Only

• Modified mRNA-Based Vaccines Elicit Robust Immune Responses and Protect Guinea Pigs From Ebola Virus Disease

  Authors:Michelle Meyer, Eric Huang, Olga Yuzhakov, Palaniappan Ramanathan, and Giuseppe CiaramellaFrom:Journal of Infectious Diseases (Vol. 217, Issue 3) Peer-Reviewed

  Feb. 1, 2018 Article

   Citation Only

• DC-SIGN Polymorphisms Associate with Risk of Hepatitis C Virus Infection Among Men who Have Sex with Men but not Among Injecting Drug Users

  Authors:Gaby S Steba, Sylvie M Koekkoek, Joost W Vanhommerig, Kees Brinkman, and David KwaFrom:Journal of Infectious Diseases (Vol. 217, Issue 3) Peer-Reviewed

  Feb. 1, 2018 Article

   Citation Only

• Human Parvovirus B19 (B19V) Up-regulates CXCR4 Surface Expression of Circulating Angiogenic Cells: Implications for Cardiac Ischemia in B19V Cardiomyopathy

  Authors:Caroline Schmidt-Lucke, Thomas Zobel, Felicitas Escher, Carsten Tschope, and Dirk LassnerFrom:Journal of Infectious Diseases (Vol. 217, Issue 3) Peer-Reviewed

  Feb. 1, 2018 Article

   Citation Only

• Immunogenicity and Safety of Yellow Fever Vaccine in Allogeneic Hematopoietic Stem Cell Transplant Recipients After Withdrawal of Immunosuppressive Therapy

  Authors:Flore Sicre de Fontbrune, Cecile Arnaud, Morgane Cheminant, Aude Boulay, and Johana KonopackiFrom:Journal of Infectious Diseases (Vol. 217, Issue 3) Peer-Reviewed

  Feb. 1, 2018 Article

   Citation Only

• Functional Conservation of the AMA1 Host-Cell Invasion Ligand Between P. falciparum and P. vivax: A Novel Platform to Accelerate Vaccine and Drug Development

  Authors:Damien R Drew, Paul R Sanders, Gretchen Weiss, Paul R Gilson, and Brendan S CrabbFrom:Journal of Infectious Diseases (Vol. 217, Issue 3) Peer-Reviewed

  Feb. 1, 2018 Article

   Citation Only